tetano
Editor, Senior Moderator
Int J Epidemiol
. 2026 Aug 18;55(5):dyag152.
doi: 10.1093/ije/dyag152.
Carla Morvan 1 , Johanna Lepeule 2 , Emmanuelle Lavaine 1
Affiliations
Background: Despite growing evidence on the health effects of air pollution, few studies have examined its impact on COVID-19 hospitalizations and deaths, and none have explicitly accounted for preexisting comorbidities in a causal framework. This study addresses this gap by investigating the relationship between PM2.5 exposure and COVID-19 severity. We place particular emphasis on the role of comorbidities, which can increase vulnerability to COVID-19 and may interact with air pollution exposure.
Methods: We use an exhaustive dataset covering the entire French territory over 2020-1, totaling more than 3.5 million weekly observations. The data include information on COVID-19 mortality and hospitalizations, disaggregated by age, sex, and municipality, along with detailed records on preexisting conditions. To address endogeneity, we employ a two-stage least squares approach, using wind direction as an instrument for local PM2.5 concentrations.
Results: We find no significant effect of PM2.5 exposure on COVID-19 mortality or hospitalizations among individuals without preexisting conditions. However, when accounting for comorbidities, a 10 μg/m3 increase in PM 2.5 was associated with higher COVID-19 mortality rates (1.5 per 100 000, 95% CI: 0.8-2.2), particularly among patients with respiratory (0.9 per 100 000, 95% CI: 0.4-1.4), and cardiovascular diseases (0.6 per 100 000, 95% CI: 0.1-1.1).
Conclusions: These findings underscore the importance of incorporating comorbidities when assessing the health effects of air pollution during a pandemic. Our results also show that the effects of PM2.5 are driven by the oldest age groups, who are both more vulnerable to COVID-19 and more likely to have comorbidities.
Keywords: COVID-19; PM2.5; air pollution; mortality.
. 2026 Aug 18;55(5):dyag152.
doi: 10.1093/ije/dyag152.
When air pollution meets comorbidities: evidence on the causal effect of PM2.5 on COVID-19 hospitalizations and deaths
Carla Morvan 1 , Johanna Lepeule 2 , Emmanuelle Lavaine 1
Affiliations
- PMID: 42656020
- DOI: 10.1093/ije/dyag152
Abstract
Background: Despite growing evidence on the health effects of air pollution, few studies have examined its impact on COVID-19 hospitalizations and deaths, and none have explicitly accounted for preexisting comorbidities in a causal framework. This study addresses this gap by investigating the relationship between PM2.5 exposure and COVID-19 severity. We place particular emphasis on the role of comorbidities, which can increase vulnerability to COVID-19 and may interact with air pollution exposure.
Methods: We use an exhaustive dataset covering the entire French territory over 2020-1, totaling more than 3.5 million weekly observations. The data include information on COVID-19 mortality and hospitalizations, disaggregated by age, sex, and municipality, along with detailed records on preexisting conditions. To address endogeneity, we employ a two-stage least squares approach, using wind direction as an instrument for local PM2.5 concentrations.
Results: We find no significant effect of PM2.5 exposure on COVID-19 mortality or hospitalizations among individuals without preexisting conditions. However, when accounting for comorbidities, a 10 μg/m3 increase in PM 2.5 was associated with higher COVID-19 mortality rates (1.5 per 100 000, 95% CI: 0.8-2.2), particularly among patients with respiratory (0.9 per 100 000, 95% CI: 0.4-1.4), and cardiovascular diseases (0.6 per 100 000, 95% CI: 0.1-1.1).
Conclusions: These findings underscore the importance of incorporating comorbidities when assessing the health effects of air pollution during a pandemic. Our results also show that the effects of PM2.5 are driven by the oldest age groups, who are both more vulnerable to COVID-19 and more likely to have comorbidities.
Keywords: COVID-19; PM2.5; air pollution; mortality.